Download presentation
Presentation is loading. Please wait.
Published byEdwin Hawkins Modified over 9 years ago
1
Vaccine in National Immunization Programme Update March 2015
2
Countries with Hib vaccine in the national immunization programme; and planned introductions in 2015 * Includes partial introduction Data source: WHO/IVB Database, as of 05 March 2015 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved. Introduced* to date (192 countries or 99%) Not Available, Not Introduced/No Plans (2 countries or 1%) Not applicable
3
Countries using IPV vaccine to date This information is available from the website @: IPV Introduction, OPV Withdrawal and Routine Immunization Strengthening: http://www.who.int/immunization/diseases/poliomyelitis/in activated_polio_vaccine/en/ IPV Introduction, OPV Withdrawal and Routine Immunization Strengthening http://www.who.int/immunization/diseases/poliomyelitis/in activated_polio_vaccine/en/ (click on the hyperlink to access the website – on its right hand column a slide set presentation in downloadable)
4
Countries with Pneumococcal Conjugate vaccine in the national immunization programme; and planned introductions in 2015 * Includes partial introduction Data source: WHO/IVB Database, as of 05 March 2015 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved. Introduced* to date (120 countries or 61.9%) Planned introductions in 2015(10 countries or 5.2%) Not Available, Not Introduced/No Plans by 2015 (64 countries or 33%) Not applicable
5
Countries with Rotavirus vaccine in the national immunization programme; and planned introductions in 2015 * Includes partial introduction Data source: WHO/IVB Database, as of 05 March 2015 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved. Introduced* to date (77 countries or 39.7%) Planned introductions in 2015(9 countries or 4.6%) Not Available, Not Introduced/No Plans by 2015 (108 countries or 55.7%) Not applicable
6
Countries with HPV vaccine in the national immunization programme * ncludes partial introduction but not countries where vaccination is temporarily interrupted Data source: WHO/IVB Database, as of 05 March 2015 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved. Introduced* to date (63 countries or 32.5%) Not Available, Not Introduced (131 countries or 67.5%) Not applicable
7
Countries using Measles Second Dose vaccine to date; and planned introductions in 2015 Data source: WHO/IVB Database, as of 05 March 2015 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved. Introduced to date (153 countries or 78.9%) Planned introductions in 2015( 4 countries or 2.1%) Not Available, Not Introduced/No Plans by 2015 (37 countries or 19.1%) Not applicable
8
Countries with Rubella vaccine in the national immunization programme; and planned introductions in 2015 Data source: WHO/IVB Database, as of 05 March 2015 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved. Introduced to date (141 countries or 72.7%) Planned introductions in 2015(7 countries or 3.6%) Not Available, Not Introduced/No Plans by 2015 (46 countries or 23.7%) Not applicable
9
Countries and Territories using Yellow fever* vaccine to date * WHO considers that 48 countries/Territories are at risk for Yellow fever Data source: WHO/IVB Database, as of 19 December 2014 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2014. All rights reserved. Introduced to date(33 countries or 69%) Introduced in High risk areas(4 countries or 8%) At risk but not introduced(11 countries or 23%) Not Available / Not at risk(147 countries or 76%) Not applicable
10
Countries and Territories using JE vaccine to date Data source: WHO/IVB Database, as of 19 December 2014 International travel Health Database (http://www.who.int/wer/2013/wer8834.pdf?ua=1) Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2014. All rights reserved. At risk countries/areas but not introduced (21 countries or 48%) Introduced to date(7 countries/territories or 30%) Introduced in parts of the country (5 countries or 22%) Not applicable
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.